# US 2010/0145008 A1 · Ob-fold used as scaffold for engineering new specific binders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0145008 A1
- Document ID: US20100145008A1
- Status: Published application
- Kind: A1
- Application number: 12/517,643
- Filed: 2007-12-04
- Published: 2010-06-10
- Earliest claimed: 2006-12-04
- Assignees: Institut Pasteur; Centre National De La Recherche Scientifique
- Inventors: Frederic Pecorari; Pedro Alzari
- Web page: https://patentgrep.com/patent/US20100145008A1

## CPC

- C40B 40/10: Libraries containing peptides or polypeptides, or derivatives thereof
- C07K 14/195: from bacteria
- C07K 16/1228: Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C07K 16/1232: Escherichia (G)
- C07K 16/4283: {against an allotypic or isotypic determinant on Ig}
- C12N 15/1041: {Ribosome/Polysome display, e.g. SPERT, ARM}
- C07K 2318/20: Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention pertains to the field of protein engineering, and provides means for obtaining stable molecules that specifically bind to a target selected amongst a large variety of ligands families. In particular, the present invention provides methods for obtaining a molecule specifically binding to a target of interest, through a combinatorial mutation/selection approach with an OB-fold protein as a starting molecule. In particular, the target of interest can be of a different chemical nature form that of the native target of the OB-fold protein used as the starting molecule.

## Claims

### Claim at position 1

1-3. (canceled)

### Claim 4

A combinatorial library corresponding to the randomization of 5 to 32 of the binding interface of an OB-fold protein with its native ligand.

### Claim 5 (depends on 4)

The combinatorial library of claim 4, further comprising an insertion of 1 to 15 random amino acid residues in loop 3, an insertion of 1 to 15 random amino acid residues in loop 4, an insertion of 1 to 20 random amino acid residues in loop 1, or a combination thereof.

### Claim 6 (depends on 4)

The combinatorial library of claim 4, wherein the OB-fold protein is Sac7d or Sac7e from Sulfolobus acidocaldarius, or Sso7d, from Sulfolobus solfataricus, or DBP 7 from Sulfolobus tokodaii, or Ssh7b from Sulfolobus shibatae, or Ssh7a from Sulfolobus shibatae, or p7ss from Sulfolobus solfataricus.

### Claim 7 (depends on 6)

The combinatorial library of claim 6, which corresponds to the randomization of residues of Sac7d selected from the group consisting of V2, K3, K5, K7, Y8, K9, G10, E14, T17, K21, K22, W24, V26, G27, K28, M29, S31, T33, D36, N37, G38, K39, T40, R42, A44, S46, E47, K48, D49, A50 and P51.

### Claim 8 (depends on 7)

The combinatorial library of claim 7, which corresponds to the randomization of 11, 12, 13, 14, 15, 16, 17 or 18 residues of Sac7d selected from the group consisting of K7, Y8, K9, K21, K22, W24, V26, K28, M29, S31, T33, K39, T40, R42, A44, S46, E47 and K48.

### Claim 9 (depends on 8)

The combinatorial library of claim 8, which corresponds to the randomization of 11, 12, 13, 14, 15 or 16 residues of Sac7d selected from the group consisting of K7, Y8, K9, K21, K22, W24, V26, K28, M29, S31, T33, K39, T40, R42, A44 and S46.

### Claim 10 (depends on 9)

The combinatorial library of claim 9, in which the randomized residues comprise at least the residues K7, Y8, K9, W24, V26, M29, S31, T33, R42, A44 and
S46 of Sac7d.

### Claim 11 (depends on 10)

The combinatorial library of claim 10, which corresponds to the randomization of the residues K7, Y8, K9, W24, V26, M29, S31, T33, R42, A44 and S46 of Sac7d.

### Claim 12 (depends on 10)

The combinatorial library of claim 10, in which one, two or three additional residues of Sac7d selected amongst from the group consisting of K21, K22 and T40 are also randomized.

### Claim 13 (depends on 12)

The combinatorial library of claim 12, which corresponds to the randomization of the residues K7, Y8, K9, K21, K22, W24, V26, M29, S31, T33, R42, A44 and S46 of Sac7d.

### Claim 14 (depends on 12)

The combinatorial library of claim 12, which corresponds to the randomization of the residues K7, Y8, K9, K21, K22, W24, V26, M29, S31, T33, T40, R42, A44 and S46 of Sac7d.

### Claim 15 (depends on 6)

The combinatorial library of claim 6, wherein 1 to 15 random amino acid residues are inserted in the region corresponding to the amino acids in position 25 to 30 of Sac7d, to 15 random amino acid residues are inserted in the region corresponding to the amino acids in position 35 to 40 of Sac7d, 1 to 20 random amino acid residues are inserted in the region corresponding to the amino acids in position 7 to 12 of Sac7d, or a combination thereof.

### Claim 16 (depends on 6)

The combinatorial library of claim 6, wherein 1 to 4 amino acid residues selected from the group consisting of A59, R60, A61 and E64 are deleted.

### Claim 17

(canceled)

### Claim 18 (depends on 4)

A process for engineering a molecule specifically binding to a target, comprising selecting, in a combinational library according to claim 4, variants of said OB-fold protein which bind to said target.

### Claim 19 (depends on 18)

The process of claim 18, wherein said target is a peptide, a protein, an oligosaccharide, a single-stranded DNA, a double-stranded DNA, an RNA, a metallic ion, or a carbohydrate.

### Claim 20 (depends on 18)

The process of claim 18, wherein said selecting is performed by ribosome display.

### Claim 21 (depends on 20)

The process of claim 20, in which 2, 3, 4 or 5 rounds of selection are performed by ribosome display.

### Claim 22 (depends on 20)

The process of any of claim 20, further comprising isolating and characterizing a molecule specifically binding to said target.

### Claim 23 (depends on 22)

The process of claim 22, wherein isolating and characterizing comprises:
(i) mRNAs from a pool selected by ribosome display are reversed-transcribed and amplified by PCR, and the resulting DNAs are cloned into expression vectors;
(ii) bacteria are transformed by said expression vectors and individual clones are grown; and
(iii) proteins extracted from said bacterial clones are tested for their binding to the target.

### Claim 24 (depends on 22)

The process claim 22, further comprising making a fusion protein comprising, as a first moiety, the isolated and characterized molecule, and at least a second moiety.

### Claim 25 (depends on 24)

The process of claim 24, wherein said at least second moiety is selected from the group consisting of enzymes, marker proteins, therapeutic proteins, and binders with different specificities than said first moiety.

### Claim 26 (depends on 18)

A protein obtained through the process according to claim 18, wherein said protein specifically binds to PulD, and wherein the sequence thereof is selected from the group consisting of SEQ ID Nos: 2, 3, 4, 5, 6, 7 and 8.

### Claim 27 (depends on 18)

A protein obtained through the process according to claim 18, wherein said protein specifically binds to GarA, and wherein the sequence thereof is SEQ ID No: 47.

### Claim 28 (depends on 4)

The combinatorial library according to claim 4, corresponding to the randomization of 8 to 20 of the binding interface of an OB-fold protein with its native ligand.

### Claim 29 (depends on 4)

The combinatorial library according to claim 4, corresponding to the randomization of 11 to 16 of the binding interface of an OB-fold protein with its native ligand.

### Claim 30 (depends on 6)

The combinatorial library of claim 6, wherein 1 to 15 random amino acid residues are inserted between G27 and K28 of Sac7d, 1 to 15 random amino acid residues are inserted between N37 and G38 of Sac7d, 1 to 20 random amino acid residues are inserted between K9 and G10 of Sac7d, or a combination thereof.
